COX-2 inhibitor
COX-2 inhibitor has been studied in 5 papers since 2016: 2 observational studies in people, 2 in animals, 1 review. The newest paper, Aug 6, 2025: “Effects of NSAIDs on Early CKD Development: A 10-Year Population-Based Study Using the Korean Senior Cohort”.
5 papers study it3 findingsUpdated
See all 5 papers on COX-2 inhibitor
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“and a 55% decrease among cyclooxygenase-2 (COX-2) inhibitor users (HR 0.45, 95% CI 0.26-0.78) during 6.3 years of average follow-up”
1 of its findings points the other way.
- 2 independent labs in 2 countries
- 1 finding against
- Funders: Brain & Behavior Research Foundation and others
- Humans2
- Animals2
What did studies of COX-2 inhibitor find?
1Studies of COX-2 inhibitor measured one outcome, glucose uptake.
Glucose uptake
no changein mice1upin mice1
1 study
Glucose uptake
no changein mice1upin mice1
COX-2 inhibitor showed no clear effect on glucose uptake in TgAPP-2576 mice.
“COX-2 inhibition failed to stimulate glucose uptake in these mice”
Animalsin TgAPP-2576 micehippocampus
Neuropharmacology
COX-2 inhibitor increases glucose uptake in mice (acute hippocampal slices).
“the selective inhibition of COX-2, rather than that of FAAH, MAGL or α,βDH6/12, also stimulates the uptake of glucose in hippocampal slices of middle-aged mice”
Animalsacute hippocampal sliceshippocampus
Neuropharmacology
What is COX-2 inhibitor linked with?
1Studies link COX-2 inhibitor with age-related macular degeneration.
Age-related macular degeneration
downin humans1HR 0.45
1 study
Age-related macular degeneration
downin humans1HR 0.45
COX-2 inhibitor is linked with a lower risk of age-related macular degeneration in humans (HR 0.45, 95% CI 0.26-0.78).
“and a 55% decrease among cyclooxygenase-2 (COX-2) inhibitor users (HR 0.45, 95% CI 0.26-0.78) during 6.3 years of average follow-up”
Humans6.3 yearsfemales
Drugs & aging